Industry News

Leading Industry Speakers Lined-Up for 44th IHF World Hospital Congress

By HospiMedica International staff writers
01 Nov 2021

Image: 44th IHF World Hospital Congress (Photo courtesy of The International Hospital Federation)

Leaders and decision-makers of hospitals, health services, and healthcare organizations will gather at the 44th World Hospital Congress organized by The International Hospital Federation (Geneva, Switzerland) in Barcelona, Spain on 8-11 November to engage in meaningful discussions and share relevant experiences around healthcare transformations.

The 2021 World Hospital Congress will be one of the first hybrid healthcare management events that will take place in Europe in 2021. With the overarching theme "People on board: Transforming healthcare by blending agility, responsiveness, and resilience", the 44th World Hospital Congress will present over 60 sessions where more than 200 renowned speakers will gather to share their knowledge and good practices on healthcare transformations enacted across the globe. The event will bring together more than 200 healthcare experts, leading industry thinkers, and best practice presenters at over 60 sessions around nursing leadership, humanizing technology, COVID-19 vaccination, the next global pandemic, etc.

Attendees will get the opportunity to listen to Dr. Hans Kluge, Regional Director for Europe at the World Health Organization (WHO) as he gives his keynote address. Dr. Kluge has been leading the Division of Health Systems and Public Health at WHO/Europe for a decade, and his vision for the WHO European Region is “United action for better health”, working in partnership to achieve universal health coverage, address health emergencies, and promote healthier populations.

Additionally, global healthcare leaders will speak at several plenary sessions across the four-day event. Dr. Bechara Choucair, White House COVID-19 Vaccinations Coordinator, Dr. Josep Campistol, CEO of Hospital Clínic Barcelona, and Bertrand Levrat, CEO of Geneva University Hospital (HUG), and Wright Lassiter, President and CEO of Henry Ford Health System; Chair-Elect of the American Hospital Association, US, will speak at the plenary session, “Getting ready for the next global pandemic: European and North American perspectives.” Dr. Liisa Maria Voipio Pulkki, Director General and Chief Medical Officer of the Ministry of Social Affairs and Health, Finland, will speak at the plenary session, “Harnessing innovations to build back better: European lessons from the pandemic.”

Dr. Wahid Majrooh, former Minister of Public Health of Afghanistan, will participate in “Resilience and Impartiality; The Afghanistan Hospital Sector during the Era of COVID-19: A Fireside Conversation with the Former Minister of Public Health.” Lord Nigel Crisp, former CEO at NHS in England and Former Permanent Secretary of the United Kingdom Department of Health, will speak at the plenary session, “Nursing leadership in transforming healthcare during a world-wide pandemic: Examples from the field.”

Dr. Anne Snowdon, Chief Scientific Research Officer of HIMSS and Dr. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals Enterprise Ltd., India, will speak at the plenary session, “Humanizing technology for smart healthcare delivery: The COVID-19 impact.” Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers & Associations, will participate in the parallel session, “An inside look at the pharmaceutical industry’s response to the COVID-19 pandemic and how it is preparing to face the antimicrobial resistance challenge and future pandemics.”

Related Links:
The International Hospital Federation 

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

21 Jan 2022
Global Immunofluorescence Assay (IFA) Market to Surpass USD 4 Billion by 2028 Due to Growing Burden of Infectious Diseases
The global immunofluorescence assay (IFA) market is expected to reach USD 4.01 billion by 2028, driven by the increasing global healthcare burden of chronic and infectious diseases, rising application of immunofluorescence assays in clinical diagnostics and research, and growing investments and expenditure in healthcare sector.
Read More
21 Jan 2022
Global Digital X-Ray Systems Market to Be Driven by AI-Based Systems and Robotic Devices
The global digital X-ray systems market was valued at USD 11.74 billion in 2020 and is expected to grow at a CAGR of 7.45% during the forecast period 2021 to 2026, due to the rising number of cancer patients and increasing cases of orthopedic diseases/tumors, cardiovascular diseases (CVD), pneumonia, and dental disorders, among others.
Read More
20 Jan 2022
Illumina and Boehringer Ingelheim Partner to Develop Companion Diagnostics (CDx) for Cancer Treatment
Illumina Inc. (San Diego, CA, USA) has entered into a partnership with Boehringer Ingelheim (Ingelheim am Rhein, Germany; to develop companion diagnostics (CDx) for several programs in the latter’s oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.
Read More
20 Jan 2022
Thermo Fisher and Oncocyte to Jointly Develop IVD Test Kits and Companion Diagnostic Tests in Precision Oncology
Oncocyte Corporation (Irvine, CA, USA) has entered into a development and co-marketing agreement for two distributed in vitro diagnostic (IVD) assays on Thermo Fisher Scientific’s (Waltham, MA, USA) Ion Torrent Genexus System. The agreement also grants Oncocyte rights to develop future companion diagnostics on the Genexus System.
Read More
18 Jan 2022
Global Coagulation Analyzers Market Driven by Growing Awareness About Timely Diagnosis of Blood Clots
The global coagulation analyzers market is expected to reach USD 11.7 billion by 2028, driven by the increasing understanding of blood clots and the fact that they can be avoided with early detection.
Read More
17 Jan 2022
Mobile C-Arms Market to Surpass USD 1.6 Billion in 2027 Due to Growing Preference for Minimally Invasive Surgeries
The global mobile C-arms market is expected to grow at a CAGR of 5.2% from USD 1.07 billion in 2019 to USD 1.61 billion in 2027, driven primarily by an increase in the global geriatric population, rising burden of chronic and acute diseases across the world, increasing volumes of orthopedic, cardiac, neurological, and oncological surgical procedures, and growing preference for minimally invasive surgeries.
Read More
14 Jan 2022
Medlab Middle East to Reveal Latest Innovations and Technologies in Mobile Labs for COVID-19 Testing
The latest technology and innovation in the global fight against COVID-19 and beyond will be on show at the next edition of Medlab Middle East when it returns to the Dubai World Trade Center from 24-27 January 2022 with mobile molecular testing and diagnosis stations, or ‘laboratories on wheels’, from companies such as Seegene, Inc. (Seoul, Korea) taking center stage.
Read More
13 Jan 2022
Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders
The global coagulometers market is being driven by a rise in the incidence and prevalence of blood disorders such as hemophilia that is fueling the demand for more diagnostic tools.
Read More
11 Jan 2022
Medlab Middle East to Return as Standalone Event in 2023
Informa Markets (London, UK), organizers of Medlab Middle East, have announced that the MENA region’s leading exhibition for the laboratory industry will return to a standalone event in 2023.
Read More
Copyright © 2000-2022 All rights reserved. | Terms And Conditions